EMERGENT BIOSOLUTIONS AND VALNEVA INITIATE PHASE 1 CLINICAL STUDY TO EVALUATE VACCINE CANDIDATE AGAINST ZIKA VIRUS
pharmaceutical investing Actinium Announces Submission of IND For Actimab-A in Combination with CLAG-M
Miivo Launches Low Cost, Fully Automated AI Customer Insights Tool for Small to Medium Size Businesses
Goldgroup Accelerates Growth Strategy Following Transformational Merger; Company Advances Multi-Asset Drill Programs, Mine Development and Expansion Plans
